Regulatory Milestone — DOJ Rescheduling to Schedule III
U.S. DOJ issued an order rescheduling medical cannabis from Schedule I to Schedule III (Apr 23). Management views this as a constructive step that could unlock improved access to capital, credit card acceptance, banking engagement, and potential up-listing opportunities; DEA administrative hearing on adult-use rescheduling begins June 29.
Revenue and Adjusted EBITDA Ahead of Guidance
Q1 net revenue was $116.9 million (down 3% sequentially) and adjusted EBITDA was $26.3 million; management stated both revenue and adjusted EBITDA came in ahead of the company's guidance range and broader market expectations.
Improved Gross Profit Margin
Adjusted gross profit was $53.9 million (down 1.4% q/q) while adjusted gross profit margin expanded by 70 basis points to 46.1%, driven by increased verticality, optimized menu assortment and stronger margins on third-party product sales.
Retail Mix and Verticality Progress
Retail now represents 71.1% of net revenue (up 60 basis points sequentially) reflecting a continued shift to vertical sales that supports margin expansion and improved price per gram.
Loyalty and Payment Momentum
Loyalty membership grew over 34% sequentially; ~89% of transactions tied to Ascenders Club members who spent nearly 20% more per transaction. Ascend Pay adoption rose from 6.2% to 8% of transactions, a 29% increase quarter-over-quarter.
CPG and Brand Share Gains
Ascend reached the #2 brand house by sales and units across Illinois, Massachusetts and New Jersey combined; combined market share in these states grew 11% sequentially. Infused flower was up 37.5% sequentially. High Wired gained 44% more share and ranked #1 infused flower across the three states. Ozone relaunch drove a 2.6% vertical sales uplift.
Retail Expansion / Densification
Year-to-date the company added 5 new stores (3 Northeast, 2 Midwest) and has 10 additional stores in the pipeline; management expects to expand from 51 stores to at least 60 by year-end (subject to approvals) as part of a densification strategy to drive operating leverage.
Balance Sheet Cushion and Capital Plan
Ended Q1 with $60.9 million in cash and no major debt maturities until July 2029. 2026 CapEx expected to be ~ $20 million, with most spend directed to new store openings and tuck-in M&A optionality.
Localized Sales Strengths
Ohio transaction volumes increased 11.8% quarter-over-quarter driven by new store openings and a shift to consistent, transparent everyday pricing; more favorable seasonality and ramp of new stores expected to drive 2%-3% top-line growth in Q2.